STOXX 600Health Care· Belgium

ARGX

Challenger

argenx

$717.80

+1.01%

Open $708.40·Prev $710.60

as of 17 Apr

CHALLENGER

Power Core

argenx's moat is its proprietary FcRn biology platform, which enables systematic expansion across IgG-mediated autoimmune diseases from a single mechanism of action.

Published18 Apr 2026

UniverseSTOXX 600

SectorHealth Care

↑

Direction of Movement

upward

ROC 200

+48.3%